{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:56:10Z","timestamp":1790830570519,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intrahepatic cholestasis of pregnancy (ICP) is typically benign, but progression to acute liver failure (ALF) is a rare, life-threatening complication. We report a case of ALF associated with early-onset ICP managed successfully with plasma exchange-based artificial liver support system (ALSS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 29-year-old Chinese woman (G2P1) presented with abnormal liver function at 20 weeks of gestation, characterized by markedly elevated aminotransferases but only mildly increased total bile acid (TBA, 12.4 \u00b5mol\/L). Despite supportive care, she developed progressive cholestasis, hyperbilirubinemia, coagulopathy, and mild encephalopathy. Pregnancy was terminated at 23 weeks due to disease progression. Post-termination, TBA surged to 360.9 \u00b5mol\/L, indicating persistent severe cholestasis. Given the poor response to conventional therapy, sequential ALSS combining Double Plasma Molecular Adsorption System (DPMAS) and plasma exchange was initiated. The patient exhibited rapid biochemical improvement and recovered fully without liver transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case illustrates a rare clinical presentation of acute liver failure associated with early-onset intrahepatic cholestasis of pregnancy in the setting of multiple potential contributing factors. Plasma exchange-based artificial liver support may provide temporary extracorporeal support for selected patients with progressive pregnancy-associated hepatic dysfunction. Further studies are required to clarify the optimal timing, indications, and clinical benefits of this therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09844-1","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:55:27Z","timestamp":1787111727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma exchange-based artificial liver support for acute liver failure associated with early-onset intrahepatic cholestasis of pregnancy: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Yannan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoxin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"9918","key":"9844_CR1","first-page":"891","volume":"383","author":"C Williamson","year":"2014","unstructured":"Williamson C, Geenes V. Physiology and pathophysiology of intrahepatic cholestasis of pregnancy. Lancet. 2014;383(9918):891\u2013902.","journal-title":"Lancet"},{"issue":"2","key":"9844_CR2","first-page":"214","volume":"76","author":"V Keitel","year":"2022","unstructured":"Keitel V, Dr\u00f6ge C, Stepanow S, et al. Intrahepatic cholestasis of pregnancy (ICP): perspectives from human genetics. J Hepatol. 2022;76(2):214\u201326.","journal-title":"J Hepatol"},{"issue":"10174","key":"9844_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","volume":"393","author":"C Ovadia","year":"2019","unstructured":"Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results from international cohort studies and meta-analysis. Lancet. 2019;393(10174):899\u2013909.","journal-title":"Lancet"},{"issue":"2","key":"9844_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/hep.20336","volume":"40","author":"A Glantz","year":"2004","unstructured":"Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467\u201374.","journal-title":"Hepatology"},{"issue":"1","key":"9844_CR5","first-page":"38","volume":"23","author":"O Pata","year":"2010","unstructured":"Pata O, Vardar MA, Solak A, et al. Early-onset intrahepatic cholestasis of pregnancy: associated with adverse outcomes. J Matern Fetal Neonatal Med. 2010;23(1):38\u201341.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"9844_CR6","first-page":"291","volume":"46","author":"PH Dixon","year":"2000","unstructured":"Dixon PH, Weerasekera N, Linton K, et al. Heterozygous MDR3 missense mutation (R590Q) in a large kindred with intrahepatic cholestasis of pregnancy (ICP). Gut. 2000;46(2):291\u20132.","journal-title":"Gut"},{"issue":"6","key":"9844_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gut.2004.058115","volume":"54","author":"R Mullenbach","year":"2005","unstructured":"Mullenbach R, Bennett A, Tetlow N, et al. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut. 2005;54(6):829\u201332.","journal-title":"Gut"},{"issue":"1","key":"9844_CR8","first-page":"108","volume":"13","author":"Y Bacq","year":"2014","unstructured":"Bacq Y, Gendrot C, Perrotin F, et al. ABCB11 gene mutations in intrahepatic cholestasis of pregnancy. Ann Hepatol. 2014;13(1):108\u201313.","journal-title":"Ann Hepatol"},{"issue":"13","key":"9844_CR9","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1111\/1471-0528.17206","volume":"129","author":"J Girling","year":"2022","unstructured":"Girling J, Knight CL, Chappell L; Royal College of Obstetricians and Gynaecologists. Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43 June 2022. BJOG. 2022;129(13):e95\u2013e114.\u200b","journal-title":"BJOG"},{"issue":"2","key":"9844_CR10","first-page":"238","volume":"26","author":"J Liu","year":"2022","unstructured":"Liu J, Ghaziani TT, Wolf JL. Acute fatty liver of pregnancy: updates in diagnosis and management. Clin Liver Dis. 2022;26(2):238\u201350.","journal-title":"Clin Liver Dis"},{"issue":"12","key":"9844_CR11","first-page":"2375","volume":"39","author":"CW Zhang","year":"2019","unstructured":"Zhang CW, Li LJ, Yu Y, et al. Artificial liver support system in pregnant patients with liver failure: a retrospective cohort. Liver Int. 2019;39(12):2375\u201384.","journal-title":"Liver Int"},{"issue":"25","key":"9844_CR12","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMicm1901520","volume":"381","author":"JH Hoofnagle","year":"2019","unstructured":"Hoofnagle JH, Bjornsson ES. Drug-induced liver injury \u2013 types and phenotypes. N Engl J Med. 2019;381(25):2461\u201370.","journal-title":"N Engl J Med"},{"issue":"2","key":"9844_CR13","first-page":"113","volume":"13","author":"NP Chalasani","year":"2002","unstructured":"Chalasani NP, Maddrey WC. Drug-induced cholestasis. Semin Gastrointest Dis. 2002;13(2):113\u201322.","journal-title":"Semin Gastrointest Dis"},{"issue":"17","key":"9844_CR14","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3748\/wjg.15.2049","volume":"15","author":"V Geenes","year":"2009","unstructured":"Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15(17):2049\u201353.","journal-title":"World J Gastroenterol"},{"issue":"17","key":"9844_CR15","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","volume":"339","author":"M Trauner","year":"1998","unstructured":"Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med. 1998;339(17):1217\u201327.","journal-title":"N Engl J Med"},{"issue":"10","key":"9844_CR16","first-page":"1697","volume":"42","author":"FS Larsen","year":"2016","unstructured":"Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: a randomized phase II study. Intensive Care Med. 2016;42(10):1697\u2013707.","journal-title":"Intensive Care Med"},{"issue":"4","key":"9844_CR17","first-page":"386","volume":"25","author":"TJ Stahl","year":"2021","unstructured":"Stahl TJ, Wang X, Liu Q, et al. Application of plasma exchange in pregnancy-related liver failure: a systematic review. Ther Apher Dial. 2021;25(4):386\u201395.","journal-title":"Ther Apher Dial"},{"issue":"2","key":"9844_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60\u20133.","journal-title":"BMJ Evid Based Med"},{"issue":"2","key":"9844_CR19","first-page":"136","volume":"1","author":"MJ McPhail","year":"2016","unstructured":"McPhail MJ, Farne H, Senvar N, Wendon JA, Bernal W. Ability of UK criteria to determine prognosis and need for transplantation in acute liver failure: a multicentre cohort study. Lancet Gastroenterol Hepatol. 2016;1(2):136\u201341.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"9844_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"Kamath PS, Kim WR, Advanced Liver Disease Study Group. The Model for End-Stage Liver Disease (MELD). Hepatology. 2007;45(3):797\u2013805.","journal-title":"Hepatology"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09844-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:02:30Z","timestamp":1790827350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09844-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9844"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09844-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9608483\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from the patient for publication of this case report and any accompanying information.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1090"}}